Welcome to our dedicated page for Micromen Tech news (Ticker: MMTIF), a resource for investors and traders seeking the latest updates and insights on Micromen Tech stock.
Micromem Technologies Inc. (OTCQB: MMTIF; CSE: MRM) is a publicly traded company that develops and commercializes advanced sensor solutions using proprietary nanotechnology. The news flow around Micromem centers on technology milestones, research collaborations, financing activities, and regulatory disclosures, giving investors and observers insight into the company’s progress in sensor development and commercialization.
Recent news releases highlight Micromem’s work on nanowire-based gas and liquid-phase biochemical sensor platforms. The company has reported advances in high-sensitivity gas detection using multi-nanowire sensing arrays with tunable amplification, as well as liquid-phase sensors engineered to detect disease-associated biomarkers at very low concentrations. These updates often describe how the technology is fabricated using standard photolithography processes and how it may be adapted to industrial, environmental, and biomedical applications.
Micromem’s news also covers its collaboration with the University of Toronto and the Department of National Defence on nanowire field-effect transistor biochemical sensors. The company provides updates on the status of this collaboration, related research, and potential applications in defense, environmental monitoring, and diagnostic tools.
In addition to technology and collaboration updates, Micromem issues news about non-brokered private placements, including the terms of units, warrants, and intended use of proceeds for working capital. Regulatory and disclosure-related items, such as the filing of Form 20-F and Form 6-K with the U.S. Securities and Exchange Commission and filings on SEDAR+, are also communicated through news releases. Readers following Micromem’s news can track developments in its sensor platforms, research partnerships, financing transactions, and key regulatory filings over time.
Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) has announced an update following a meeting with Chevron representatives in Houston on September 25th. The company has secured access to Chevron's automated sampler system for tracer testing, which is important for Micromem's ARTRA device in well-mounted systems. Notably, Micromem will not pay any fees for using the system, and any intellectual property generated will remain with the company.
Chevron will introduce Micromem to the system's designer, allowing for potential modifications for use with third parties. This access is expected to save Micromem significant time and expenses in developing sampler systems for future projects. In return, Micromem will provide modified sampler designs to Chevron for their testing and potential future use.
Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) has closed a non-brokered private placement, raising gross proceeds of approximately C$354,973 by issuing 11,832,420 units at C$0.03 per unit. Each unit consists of one common share and one warrant exercisable at C$0.05 for three years. The company paid a finder's fee of about $5,611 in cash. Additionally, Micromem settled indebtedness of C$40,000 with its legal counsel by issuing 1,333,333 units at C$0.03 per unit. In total, the company issued 13,165,753 common shares and 13,165,753 warrants. The proceeds will be used for working capital, and the closing is subject to certain conditions and approvals.
Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) has confirmed a meeting with Chevron scheduled for September 25, 2024. The meeting will take place at Chevron's offices in Houston. The primary objective of this meeting is to discuss the current status of their project and develop future strategies. This announcement suggests ongoing collaboration between Micromem and Chevron, potentially indicating progress or developments in their joint venture.
Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) has successfully closed its previously announced non-brokered private placement, raising gross proceeds of approximately C$267,894. The company issued 8,929,800 common shares at C$0.03 per share and an equal number of warrants exercisable at C$0.05 per share for a three-year period. A finder's fee of about $5,520 in cash and 184,000 broker warrants was paid in connection with the placement. The proceeds are intended for working capital purposes. All securities issued are subject to a four-month holding period, and the closing is contingent on certain conditions and regulatory approvals.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.